PAHC

Phibro Animal Health Corporation [PAHC] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

PAHC Stock Summary

Top 10 Correlated ETFs

PAHC


Top 10 Correlated Stocks

PAHC


In the News

09:36 28 Mar 2024 PAHC

Phibro Stock (PAHC) Rises 7% YTD: Will the Run Continue?

Investors are optimistic about Phibro (PAHC), led by the introduction of new products and upbeat guidance.

08:56 28 Mar 2024 PAHC

Here's Why Investors Should Buy Phibro (PAHC) Stock Now

Phibro's (PAHC) diversified offerings and prospering vaccine business buoy optimism for investors.

10:45 28 Mar 2024 PAHC

Is Phibro Animal Health (PAHC) Stock Undervalued Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

12:06 28 Mar 2024 PAHC

Phibro (PAHC) Appears Well Poised on Launches, Vaccine Sales

Phibro (PAHC) is focusing on new developments along with incremental registrations and growing volumes of existing nutritional specialties and vaccine technologies.

10:46 28 Mar 2024 PAHC

Is Phibro Animal Health (PAHC) a Great Value Stock Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

04:00 28 Mar 2024 PAHC

Phibro Animal Health Corporation to Participate in Barclays Global Healthcare Conference

TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (Nasdaq: PAHC) announced today it will participate in the Barclays Global Healthcare Conference. Chief Financial Officer, Glenn David along with Chief Operating Officer, Larry Miller will address financial analysts and investors on Tuesday, March 12, 2024, at 4:35 PM ET at the Loews Miami Beach Hotel. The live audio presentation will be available on the Phibro Animal Health Corporation Investor Relations Website at https://investo.

01:01 28 Mar 2024 PAHC

What Makes Phibro (PAHC) a New Buy Stock

Phibro (PAHC) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

10:46 28 Mar 2024 PAHC

Should Value Investors Buy Phibro Animal Health (PAHC) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

03:55 28 Mar 2024 PAHC

Phibro Animal Health Corporation (PAHC) Q2 2024 Earnings Call Transcript

Phibro Animal Health Corporation (PAHC) Q2 2024 Earnings Call Transcript

08:31 28 Mar 2024 PAHC

Phibro (PAHC) Q2 Earnings and Revenues Top, Margins Down

Phibro's (PAHC) fiscal 2024 second-quarter results reflect the strong performance of the Animal Health segment.

PAHC Financial details

Company Rating
Buy
Market Cap
489.69M
Income
14.81M
Revenue
981.99M
Book val./share
6.69
Cash/share
2.28
Dividend
0.48
Dividend %
4.27%
Employees
1.92K
Optionable
No
Shortable
Yes
Earnings
01 May 2024
P/E
22
Forward P/E
18.39
PEG
-3.13
P/S
0.47
P/B
1.67
P/C
5.73
P/FCF
110.79
Quick Ratio
1.39
Current Ratio
3.39
Debt / Equity
1.89
LT Debt / Equity
1.77
-
-
EPS (TTM)
0.36
EPS next Y
0.71
EPS next Q
0.29
EPS this Y
-33.06%
EPS next Y
97.22%
EPS next 5Y
333.33%
EPS last 5Y
-9.71%
Revenue last 5Y
3.38%
Revenue Q/Q
8.06%
EPS Q/Q
-115%
-
-
-
-
SMA20
-1.96%
SMA50
10.9%
SMA100
12.7%
Inst Own
43.86%
Inst Trans
0.89%
ROA
2%
ROE
8%
ROC
0.06%
Gross Margin
30%
Oper. Margin
5%
Profit Margin
2%
Payout
94%
Shs Outstand
40.5M
Shs Float
40.28M
-
-
-
-
Target Price
18.67
52W Range
9.4-15.98
52W High
-12.93%
52W Low
+45.11%
RSI
59.15
Rel Volume
0.53
Avg Volume
151.95K
Volume
79.87K
Perf Week
4.65%
Perf Month
15.27%
Perf Quarter
3.65%
Perf Half Y
-1.21%
-
-
-
-
Beta
0.75
-
-
Volatility
0.3%, 0.44%
Prev Close
1.71%
Price
13.06
Change
3.98%

PAHC Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2023-06-30

Metric History 2019-06-302020-06-302021-06-302022-06-30 2023-06-30
2.02K2.02K2.02K2.02K2.02K
Revenue per share
20.519.7920.5923.2624.14
Net income per share
1.350.831.341.210.81
Operating cash flow per share
1.171.471.190.780.33
Free cash flow per share
0.430.630.47-0.13-0.95
Cash per share
2.022.262.32.252.01
Book value per share
5.354.655.896.486.97
Tangible book value per share
3.491.63.053.594.3
Share holders equity per share
5.354.655.896.486.97
Interest debt per share
8.3710.4710.8611.9113.03
Market cap
1.28B1.06B1.17B774.84M554.9M
Enterprise value
1.55B1.44B1.55B1.17B1.02B
P/E ratio
23.3531.6721.4915.7617.02
Price to sales ratio
1.541.331.40.820.57
POCF ratio
27.0817.9124.224.4841.69
PFCF ratio
73.934261.56-143.62-14.42
P/B Ratio
5.915.654.92.951.96
PTB ratio
5.915.654.92.951.96
EV to sales
1.871.81.851.241.05
Enterprise value over EBITDA
18.5420.7720.6314.829.44
EV to operating cash flow
32.7824.2131.993776.9
EV to free cash flow
89.4856.881.39-217.07-26.6
Earnings yield
0.040.030.050.060.06
Free cash flow yield
0.010.020.02-0.01-0.07
Debt to equity
1.512.181.791.791.81
Debt to assets
0.450.520.510.50.52
Net debt to EBITDA
3.225.415.035.024.32
Current ratio
3.022.873.042.973.33
Interest coverage
6.212.863.333.894
Income quality
0.861.770.890.640.41
Dividend Yield
0.010.020.020.030.04
Payout ratio
0.340.580.360.40.6
Sales general and administrative to revenue
00000
Research and developement to revenue
0.010.020.020.020.02
Intangibles to total assets
0.10.160.140.130.11
Capex to operating cash flow
-0.63-0.57-0.61-1.17-3.89
Capex to revenue
-0.04-0.04-0.04-0.04-0.05
Capex to depreciation
-1.08-1.05-0.92-1.13-1.52
Stock based compensation to revenue
0000-0.01
Graham number
12.769.3213.3513.311.24
ROIC
0.10.040.050.040.05
Return on tangible assets
0.080.050.070.060.04
Graham Net
-5.21-7.7-7.2-7.99-8.55
Working capital
311.94M294.6M334.79M375.4M409.72M
Tangible asset value
141.19M64.53M123.57M145.36M174.25M
Net current asset value
-44.49M-144.06M-103.89M-103.03M-103.17M
Invested capital
1.512.181.791.791.81
Average receivables
147.38M142.77M136.69M156.69M165.01M
Average payables
66.34M69.64M67.23M81.98M84.72M
Average inventory
188.25M197.49M206.49M237.74M268.36M
Days sales outstanding
70.157.764.3264.5161.02
Days payables outstanding
47.4244.3844.453.1239.66
Days of inventory on hand
128.48132.07140.49144149.07
Receivables turnover
5.216.335.685.665.98
Payables turnover
7.78.228.226.879.2
Inventory turnover
2.842.762.62.532.45
ROE
0.250.180.230.190.12
Capex per share
-0.74-0.84-0.72-0.91-1.28

Quarterly Fundamentals Overview

Last date of statement is 2023-12-31 for Q2

Metric History 2022-12-312023-03-312023-06-302023-09-30 2023-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
6.046.076.35.776.17
Net income per share
0.180.250.28-0.20.03
Operating cash flow per share
-0.060.150.50.40.78
Free cash flow per share
-0.3-0.040.230.220.51
Cash per share
1.941.912.012.272.28
Book value per share
6.636.726.986.816.69
Tangible book value per share
3.8544.34.184.08
Share holders equity per share
6.636.726.986.816.69
Interest debt per share
12.7412.8812.7213.0512.8
Market cap
543.16M620.46M554.85M511.76M469.04M
Enterprise value
986.48M1.1B1.02B986.95M949.16M
P/E ratio
18.8315.4512.06-15.9992.04
Price to sales ratio
2.222.532.182.211.88
POCF ratio
-218.2299.1327.4231.5914.86
PFCF ratio
-44.13-376.2659.3658.6722.77
P/B Ratio
2.022.281.961.871.73
PTB ratio
2.022.281.961.871.73
EV to sales
4.034.484.014.273.8
Enterprise value over EBITDA
39.659.1930.95-1.41K37.42
EV to operating cash flow
-396.34175.950.5760.9330.08
EV to free cash flow
-80.15-667.64109.5113.1446.08
Earnings yield
0.010.020.02-0.020
Free cash flow yield
-0.0200.020.020.04
Debt to equity
1.911.91.811.91.89
Debt to assets
0.530.540.520.540.53
Net debt to EBITDA
17.825.8314.17-678.8418.93
Current ratio
3.473.543.333.393.12
Interest coverage
3.562.594.54-0.152.9
Income quality
-0.350.621.76-2.0224.77
Dividend Yield
0.010.010.010.010.01
Payout ratio
0.670.480.42-0.613.82
Sales general and administrative to revenue
00000
Research and developement to revenue
000.100
Intangibles to total assets
0.120.110.110.110.11
Capex to operating cash flow
3.94-1.26-0.54-0.46-0.35
Capex to revenue
-0.04-0.03-0.04-0.03-0.04
Capex to depreciation
-1.15-0.93-1.27-0.84-1.23
Stock based compensation to revenue
00-0.0200
Graham number
5.156.126.685.532.18
ROIC
0.010.010.0200.01
Return on tangible assets
0.010.010.01-0.010
Graham Net
-8.81-8.76-8.55-8.7-8.72
Working capital
414.12M420.18M409.72M412.07M398.85M
Tangible asset value
156.08M162.18M174.25M167.63M165.16M
Net current asset value
-111.77M-107.62M-103.17M-107.03M-115.32M
Invested capital
1.911.91.811.91.89
Average receivables
147.28M152.29M158.11M156.35M149.93M
Average payables
84.43M78.13M74.81M75.53M81.81M
Average inventory
284.91M290.91M285.2M278.36M282.92M
Days sales outstanding
55.8555.9557.6958.0754.24
Days payables outstanding
43.3140.0937.2642.4845.39
Days of inventory on hand
155.5154.94140.04153.57150.6
Receivables turnover
1.611.611.561.551.66
Payables turnover
2.082.252.422.121.98
Inventory turnover
0.580.580.640.590.6
ROE
0.030.040.04-0.030
Capex per share
-0.24-0.2-0.27-0.19-0.27

PAHC Frequently Asked Questions

What is Phibro Animal Health Corporation stock symbol ?

Phibro Animal Health Corporation is a US stock , located in Teaneck of Nj and trading under the symbol PAHC

Is Phibro Animal Health Corporation buy or a sell ?

3 stock analysts have 3 predictions with a medium analyst target price of $18.67. The lowest prediction is $17 and the highest is $21

What is PAHC stock prediction ?

What is Phibro Animal Health Corporation stock quote today ?

Phibro Animal Health Corporation stock price is $13.06 today.

Is Phibro Animal Health Corporation stock public?

Yes, Phibro Animal Health Corporation is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated ETFs
Top Correlated Stocks
Similar Market Cap